Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer

10.3389/fmed.2017.00039

Saved in:
Bibliographic Details
Main Authors: Sundar, Raghav, Chenard-Poirier, Maxime, Collins, Dearbhaile Catherine, Yap, Timothy A
Other Authors: MEDICINE
Format: Article
Language:English
Published: FRONTIERS MEDIA SA 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/228507
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-228507
record_format dspace
spelling sg-nus-scholar.10635-2285072024-11-10T08:31:36Z Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer Sundar, Raghav Chenard-Poirier, Maxime Collins, Dearbhaile Catherine Yap, Timothy A MEDICINE Dr Raghav Sundar Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine precision medicine lung cancer targeted therapy imprecision clinical trials RANDOMIZED PHASE-II PREVIOUSLY TREATED PATIENTS CISPLATIN PLUS GEMCITABINE RECEPTOR TYROSINE KINASE TIVANTINIB ARQ 197 OPEN-LABEL EGFR MUTATION 1ST-LINE THERAPY DOUBLE-BLIND C-MET 10.3389/fmed.2017.00039 FRONTIERS IN MEDICINE 4 APR 2022-07-14T04:33:09Z 2022-07-14T04:33:09Z 2017-04-10 2022-07-06T08:43:40Z Article Sundar, Raghav, Chenard-Poirier, Maxime, Collins, Dearbhaile Catherine, Yap, Timothy A (2017-04-10). Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer. FRONTIERS IN MEDICINE 4 (APR). ScholarBank@NUS Repository. https://doi.org/10.3389/fmed.2017.00039 2296-858X https://scholarbank.nus.edu.sg/handle/10635/228507 en FRONTIERS MEDIA SA Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
precision medicine
lung cancer
targeted therapy
imprecision
clinical trials
RANDOMIZED PHASE-II
PREVIOUSLY TREATED PATIENTS
CISPLATIN PLUS GEMCITABINE
RECEPTOR TYROSINE KINASE
TIVANTINIB ARQ 197
OPEN-LABEL
EGFR MUTATION
1ST-LINE THERAPY
DOUBLE-BLIND
C-MET
spellingShingle Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
precision medicine
lung cancer
targeted therapy
imprecision
clinical trials
RANDOMIZED PHASE-II
PREVIOUSLY TREATED PATIENTS
CISPLATIN PLUS GEMCITABINE
RECEPTOR TYROSINE KINASE
TIVANTINIB ARQ 197
OPEN-LABEL
EGFR MUTATION
1ST-LINE THERAPY
DOUBLE-BLIND
C-MET
Sundar, Raghav
Chenard-Poirier, Maxime
Collins, Dearbhaile Catherine
Yap, Timothy A
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
description 10.3389/fmed.2017.00039
author2 MEDICINE
author_facet MEDICINE
Sundar, Raghav
Chenard-Poirier, Maxime
Collins, Dearbhaile Catherine
Yap, Timothy A
format Article
author Sundar, Raghav
Chenard-Poirier, Maxime
Collins, Dearbhaile Catherine
Yap, Timothy A
author_sort Sundar, Raghav
title Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
title_short Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
title_full Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
title_fullStr Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
title_full_unstemmed Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
title_sort imprecision in the era of precision medicine in non-small cell lung cancer
publisher FRONTIERS MEDIA SA
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/228507
_version_ 1821209407762989056